Trial | NCT00483132  Report issue

Official Title

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    232
Improved outcome of high risk lymphoblastic leukemia (ALL) with laite high dose therapy.

High dose versus conventional therapy for adult low risk T-ALL and Lymphoblastic lymphoma (LBL).
Comparison between two autograf therapeutic strategies in high risk patients Ramdomised comparison between maintenance treatment with or not interferon alpha 2 a
Study Started
Sep 30
1994
Study Completion
Apr 30
2002
Last Update
Jun 06
2007
Estimate

Drug interferon alpha 2a

Criteria 

Inclusion Criteria

ALL high risk or low risk or lymphoblastic lymphoma
age 15-55 years old
informed consent signed

Exclusion Criteria:

patients previously treated with a chemotherapy or alpha-interferon
ALL 3 (burkitt like)
No Results Posted